Dopamine agonists upregulate IL-6 and IL-8 production in human keratinocytes

NeuroImmunoModulation

Volumn 19, Issue 6, 2012, Pages 359-366

  Parrado, Andrea Cecilia ^a   Canellada, Andrea ^a   Gentile, Teresa ^a   Rey Roldn, Estela Beatriz ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Cytokine; Dopamine agonists; IL 6; IL 8; Keratinocyte

Indexed keywords

ASCORBIC ACID; CABERGOLINE; INTERLEUKIN 6; INTERLEUKIN 8; PROPRANOLOL; SULPIRIDE;

ARTICLE; CELL CULTURE; CELL LINE; CELL PROLIFERATION; CELL STIMULATION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG MECHANISM; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

CELL LINE; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; KERATINOCYTES; UP-REGULATION;

EID: 84867223396     PISSN: 10217401     EISSN: 14230216     Source Type: Journal    
DOI: 10.1159/000342140     Document Type: Article

References (43)

1. Besedovsky HO, Rey AD: Physiology of psychoneuroimmunology: a personal view. Brain Behav Immun 2007; 21: 34-44.
2. Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES: The sympathetic nerve-an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev 2000; 52: 595-638.
3. Oberbeck R: Catecholamines: physiological immunomodulators during health and illness. Curr Med Chem 2006; 13: 1979-1989.
4. Jiang JL, Qiu YH, Peng YP, Wang JJ: Immunoregulatory role of endogenous catecholamines synthesized by immune cells. Sheng Li Xue Bao 2006; 58: 309-317.
5. Sarkar C, Basu B, Chakroborty D, Dasgupta PS, Basu S: The immunoregulatory role of dopamine: an update. Brain Behav Immun 2010; 24: 525-528.
6. Pacheco R, Prado CE, Barrientos MJ, Bernales S: Role of dopamine in the physiology of T-cells and dendritic cells. J Neuroimmunol 2009; 216: 8-19.
7. Nestle FO, Di Meglio P, Qin JZ, Nickoloff BJ: Skin immune sentinels in health and disease. Nat Rev Immunol 2009; 9: 679-691.
8. Suter MM, Schulze K, Bergman W, Welle M, Roosje P, Muller EJ: The keratinocyte in epidermal renewal and defence. Vet Dermatol 2009; 20: 515-532.
9. Hernandez-Quintero M, Kuri-Harcuch W, Gonzalez Robles A, Castro-Munozledo F: Interleukin-6 promotes human epidermal keratinocyte proliferation and keratin cytoskeleton reorganization in culture. Cell Tissue Res 2006; 325: 77-90.
10. Ghazizadeh M: Essential role of IL-6 signaling pathway in keloid pathogenesis. J Nihon Med Sch 2007; 74: 11-22.
11. Kulke R, Bornscheuer E, Schluter C, Bartels J, Rowert J, Sticherling M, Christophers E: The CXC receptor 2 is overexpressed in psoriatic epidermis. J Invest Dermatol 1998; 110: 90-94.
12. Pietrzak AT, Zalewska A, Chodorowska G, Krasowska D, Michalak-Stoma A, Nockowski P, Osemlak P, Paszkowski T, Rolinski JM: Cytokines and anticytokines in psoriasis. Clin Chim Acta 2008; 394: 7-21.
13. Grando SA, Pittelkow MR, Schallreuter KU: Adrenergic and cholinergic control in the biology of epidermis: physiological and clinical significance. J Invest Dermatol 2006; 126: 1948-1965.
14. Fuziwara S, Suzuki A, Inoue K, Denda M: Dopamine D 2-like receptor agonists accelerate barrier repair and inhibit the epidermal hyperplasia induced by barrier disruption. J Invest Dermatol 2005; 125: 783-789.
15. Brenci S, Rialdi V, Rialdi G: Neuroimmunological activities of keratinocytes. International Electronic Journal on Dermopharmacological Research 2001 (articles 2001):1-6. http://www.vevy.com/relata.
16. Sivamani RK, Lam ST, Isseroff RR: Beta adrenergic receptors in keratinocytes. Dermatol Clin 2007; 25: 643-653.
17. Shome S, Rana T, Ganguly S, Basu B, Chaki Choudhury S, Sarkar C, Chakroborty D, Dasgupta PS, Basu S: Dopamine regulates angiogenesis in normal dermal wound tissues. PLoS One 2011; 6:e25215.
18. Sivamani RK, Pullar CE, Manabat-Hidalgo CG, Rocke DM, Carlsen RC, Greenhalgh DG, Isseroff RR: Stress-mediated increases in systemic and local epinephrine impair skin wound healing: potential new indication for beta blockers. PLoS Med 2009; 6:e12.
19. Pullar CE, Manabat-Hidalgo CG, Bolaji RS, Isseroff RR: Beta-adrenergic receptor modulation of wound repair. Pharmacol Res 2008; 58: 158-164.
20. Catani MV, Savini I, Rossi A, Melino G, Avig liano L: Biological role of vitamin C in keratinocytes. Nutr Rev 2005; 63: 81-90.
21. Savini I, Duflot S, Avigliano L: Dehydroascorbic acid uptake in a human keratinocyte cell line (HaCaT) is glutathione-independent. Biochem J 2000; 345: 665-672.
22. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE: Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 1988; 106: 761-771.
23. Yoshizumi M, Nakamura T, Kato M, Ishioka T, Kozawa K, Wakamatsu K, Kimura H: Release of cytokines/chemokines and cell death in UVB-irradiated human keratinocytes, HaCaT. Cell Biol Int 2008; 32: 1405-1411.
24. HaskÓ G, Szabo C, Nemeth ZH, Deitch EA: Dopamine suppresses IL-12 p40 production by lipopolysaccharide-stimulated macrophages via a beta-adrenoceptor-mediated mechanism. J Neuroimmunol 2002; 122: 34-39.
25. Leposavic G, Pilipovic I, Radojevic K, Pesic V, Perisic M, Kosec D: Catecholamines as immunomodulators: a role for adrenoceptor-mediated mechanisms in fine tuning of T-cell development. Auton Neurosci 2008; 144: 1-12.
26. Flierl MA, Rittirsch D, Nadeau BA, Sarma JV, Day DE, Lentsch AB, Huber-Lang MS, Ward PA: Upregulation of phagocyte-derived catecholamines augments the acute inflammatory response. PLoS One 2009; 4:e4414.
27. Yang EV, Kim SJ, Donovan EL, Chen M, Gross AC, Webster Marketon JI, Barsky SH, Glaser R: Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: implications for stress-related enhancement of tumor progression. Brain Behav Immun 2009; 23: 267-275.
28. Ritchie PK, Ashby M, Knight HH, Judd AM: Dopamine increases interleukin 6 release and inhibits tumor necrosis factor release from rat adrenal zona glomerulosa cells in vitro. Eur J Endocrinol 1996; 134: 610-616.
29. Beck GC, Oberacker R, Kapper S, von Zabern D, Schulte J, van Ackern K, van der Woude FJ, Yard BA: Modulation of chemokine production in lung microvascular endothelial cells by dopamine is mediated via an oxidative mechanism. Am J Respir Cell Mol Biol 2001; 25: 636-643.
30. Tebbe B, Wu S, Geilen CC, Eberle J, Kodelja V, Orfanos CE: L-Ascorbic acid inhibits UVA-induced lipid peroxidation and secretion of IL-1alpha and IL-6 in cultured human keratinocytes in vitro. J Invest Dermatol 1997; 108: 302-306.
31. Hartel C, Strunk T, Bucsky P, Schultz C: Effects of vitamin C on intracytoplasmic cytokine production in human whole blood monocytes and lymphocytes. Cytokine 2004; 27: 101-106.
32. Hartel C, Puzik A, Gopel W, Temming P, Bucsky P, Schultz C: Immunomodulatory effect of vitamin C on intracytoplasmic cytokine production in neonatal cord blood cells. Neonatology 2007; 91: 54-60.
33. Kang JS, Kim HN, Jung da J, Kim JE, Mun GH, Kim YS, Cho D, Shin DH, Hwang YI, Lee WJ: Regulation of UVB-induced IL-8 and MCP-1 production in skin keratinocytes by increasing vitamin C uptake via the redistribution of SVCT-1 from the cytosol to the membrane. J Invest Dermatol 2007; 127: 698-706.
34. Brown SW, Meyers RT, Brennan KM, Rumble JM, Narasimhachari N, Perozzi EF, Ryan JJ, Stewart JK, Fischer-Stenger K: Catecholamines in a macrophage cell line. J Neuroimmunol 2003; 135: 47-55.
35. Lombardi G, Varsaldi F, Miglio G, Papini MG, Battaglia A, Canonico PL: Cabergoline prevents necrotic neuronal death in an in vitro model of oxidative stress. Eur J Pharmacol 2002; 457: 95-98.
36. Yoshida T, Tanaka M, Suzuki Y, Sohmiya M, Okamoto K: Antioxidant properties of cabergoline: inhibition of brain auto-oxidation and superoxide anion production of microglial cells in rats. Neurosci Lett 2002; 330: 1-4.
37. Sohmiya M, Tanaka M, Okamoto K, Fujisawa A, Yamamoto Y: Synergistic inhibition of lipid peroxidation by vitamin E and A dopamine agonist, cabergoline. Neurol Res 2004; 26: 418-421.
38. Beck G, Brinkkoetter P, Hanusch C, Schulte J, van Ackern K, van der Woude FJ, Yard BA: Clinical review: immunomodulatory effects of dopamine in general inflammation. Crit Care 2004; 8: 485-491.
39. Bergmann M, Sautner T: Immunomodulatory effects of vasoactive catecholamines. Wien Klin Wochenschr 2002; 114: 752-761.
40. Basu S, Dasgupta PS: Dopamine, a neurotransmitter, influences the immune system. J Neuroimmunol 2000; 102: 113-124.
41. Grossman RM, Krueger J, Yourish D, Granelli-Piperno A, Murphy DP, May LT, Kupper TS, Sehgal PB, Gottlieb AB: Interleukin is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc Natl Acad Sci USA 1989; 86: 6367-6371.
42. Pullar CE, Grahn JC, Liu W, Isseroff RR: Beta2-adrenergic receptor activation delays wound healing. FASEB J 2006; 20: 76-86.
43. Nishida T, Nakamura M, Mishima H, Otori T, Hikida M: Interleukin 6 facilitates corneal epithelial wound closure in vivo. Arch Ophthalmol 1992; 110: 1292-1294.